Yu Tian

Zhenjiang, 212001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Soluble TREM2 drives triple-negative breast cancer progression via activation of the AKT pathway.

Soluble TREM2 drives triple-negative breast cancer progression via activation of the AKT pathway.

Journal: International immunopharmacology

Published: October 24, 2024

Role of TREM2 in immune and neurological diseases: Structure, function, and implications.

Role of TREM2 in immune and neurological diseases: Structure, function, and implications.

Journal: International immunopharmacology

Published: June 20, 2024

S1PR1-dependent migration of ILC3s from intestinal tissue to the heart in a mouse model of viral myocarditis.

S1PR1-dependent migration of ILC3s from intestinal tissue to the heart in a mouse model of viral myocarditis.

Journal: Journal of leukocyte biology

Published: October 03, 2022

Hsa_circRNA_0040462: a sensor of cells' response to CAP treatment with double-edged roles on breast cancer malignancy.

Hsa_circRNA_0040462: a sensor of cells' response to CAP treatment with double-edged roles on breast cancer malignancy.

Journal: International journal of medical sciences

Published: September 09, 2021

HMGB1 is a Potential and Challenging Therapeutic Target for Parkinson's Disease.

HMGB1 is a Potential and Challenging Therapeutic Target for Parkinson's Disease.

Journal: Cellular and molecular neurobiology

Published: July 14, 2021

IL-22 ameliorated cardiomyocyte apoptosis in cardiac ischemia/reperfusion injury by blocking mitochondrial membrane potential decrease, inhibiting ROS and cytochrome C.

IL-22 ameliorated cardiomyocyte apoptosis in cardiac ischemia/reperfusion injury by blocking mitochondrial membrane potential decrease, inhibiting ROS and cytochrome C.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: February 16, 2021

lncRNA187415.1 silence in BCAMs ameliorated breast cancer progression by blocking C/EBPβ-lncRNA187415.1-CISH axis and reversing pro-tumor characteristic of BCAMs.

lncRNA187415.1 silence in BCAMs ameliorated breast cancer progression by blocking C/EBPβ-lncRNA187415.1-CISH axis and reversing pro-tumor characteristic of BCAMs.

Journal: Clinical and translational medicine

Published: January 25, 2021

Reg3β: A Potential Therapeutic Target for Tissue Injury and Inflammation-Associated Disorders.

Reg3β: A Potential Therapeutic Target for Tissue Injury and Inflammation-Associated Disorders.

Journal: International reviews of immunology

Published: January 11, 2021

Diagnostic Performance of [18F]-Labeled PET/CT Tracers for Lymph Node/Bone Metastasis and Biochemical Recurrence Detection in Advanced Prostate Cancer: A Meta-Analysis.

Diagnostic Performance of [18F]-Labeled PET/CT Tracers for Lymph Node/Bone Metastasis and Biochemical Recurrence Detection in Advanced Prostate Cancer: A Meta-Analysis.

Journal: Urologia internationalis

Published: November 25, 2020

ILC2-derived IL-9 inhibits colorectal cancer progression by activating CD8+ T cells.

ILC2-derived IL-9 inhibits colorectal cancer progression by activating CD8+ T cells.

Journal: Cancer letters

Published: October 19, 2020

Analysis of KRAS mutations in circulating tumor DNA and colorectal cancer tissue.

Analysis of KRAS mutations in circulating tumor DNA and colorectal cancer tissue.

Journal: Biotechnic & histochemistry : official publication of the Biological Stain Commission

Published: September 03, 2020

HMGB1 A box protects neurons by potently inhibiting both microglia and T cell-mediated inflammation in a mouse Parkinson's disease model.

HMGB1 A box protects neurons by potently inhibiting both microglia and T cell-mediated inflammation in a mouse Parkinson's disease model.

Journal: Clinical science (London, England : 1979)

Published: May 05, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026